Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.330
+0.220 (7.07%)
At close: Aug 13, 2025, 4:00 PM
3.240
-0.090 (-2.70%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
Sana Biotechnology Employees
Sana Biotechnology had 194 employees as of December 31, 2024. The number of employees decreased by 134 or -40.85% compared to the previous year.
Employees
194
Change (1Y)
-134
Growth (1Y)
-40.85%
Revenue / Employee
n/a
Profits / Employee
-$1,299,907
Market Cap
791.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 194 | -134 | -40.85% |
| Dec 31, 2023 | 328 | -93 | -22.09% |
| Dec 31, 2022 | 421 | 35 | 9.07% |
| Dec 31, 2021 | 386 | 121 | 45.66% |
| Dec 31, 2020 | 265 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SANA News
- 5 days ago - Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued - Seeking Alpha
- 7 days ago - Sana Biotechnology Announces Pricing of Public Offering - GlobeNewsWire
- 7 days ago - Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 8 days ago - Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 9 days ago - Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes - GlobeNewsWire
- 7 weeks ago - Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - GlobeNewsWire
- 7 weeks ago - Two Biotech Stocks Poised For Big Moves On Monday - Benzinga
- 2 months ago - Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions - GlobeNewsWire